MEQUON, Wis., July 7, 2026 /PRNewswire/ -- Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced an exclusive licensing and manufacturing agreement with ...
Vector Science & Therapeutics (PAIN.V) said Monday that the first of four planned manufacturing suites at its LyoGenesis Manufacturing facility in Wisconsis is now producing pharma-grade peptides. The ...
Vector Science and Therapeutics Corp. ("Vector" or the "Company") (TSXV: PAIN) today announced that it has filed a provisional patent application with the United States Patent and Trademark Office ...
14-Year MLB Veteran and 2016 World Series Champion Joins Valor, Vector's Athlete Platform, to Make Sure the Next Generation Plays Longer and Hurts Less MEQUON, Wis., June 12, 2026 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results